Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca unveils plans for new US R&D centre

The site, scheduled for completion in 2026, will also include the headquarters of Alexion

Cambridge MA

AstraZeneca (AZ) has revealed plans to open a new US life sciences and innovation site in Cambridge, Massachusetts.

The new facility will serve as both a strategic R&D centre for AZ and as Alexion’s new corporate headquarters. Alexion, one of AZ’s subsidiaries, was acquired by the company in July 2021.

The scheduled date of completion of its new site is 2026, and the facility will be in close proximity to a host of pharma, academic and biotechnology institutions. In this way, AZ hopes to encourage further innovation and collaboration, enhanced by local access to future talent.

Pascal Soriot, CEO, AstraZeneca, said: “Our combined company has already successfully leveraged internal scientific synergies, and this move will act as a catalyst for even more external collaboration and innovation.

“Kendall Square, Cambridge, is at the heart of the life sciences and innovation hub of the greater Boston area, and our new site will put us right at the centre of this space. The move will provide access to some of the most innovative partners in academia and biotech, offering opportunities to accelerate our growth and collaborate with like-minded organisations as we continue to push the boundaries of science to deliver advances for patients.”

The new site will contain over 570,000 square feet of R&D and commercial space that will enable around 1,500 R&D, corporate and commercial staff to come together in a one purpose-built space, with room for future expansion.

The building will align with AZ’s commitment to sustainability, and the company hopes the new site will be awarded platinum Leadership in Energy & Environmental Design (LEED) certification.

Article by
Fleur Jeffries

29th April 2022

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Virtual MSL/Sales training programs and events
Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
Omnichannel strategies to revolutionize the healthcare professional experience
Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...